Behyar Zoghi, MD, PhD, FACP is a Persian-American Transplant Physician, triple Board Certified in Internal Medicine, Hematology and Medical Oncology. He practices with the Adult Blood and Marrow Stem Cell Transplant program at Texas Transplant Institute and Methodist Hospital, a member of the Sarah Cannon Blood Cancer Network.
Dr. Zoghi received both MD and PhD from Texas A&M College of Medicine. He subsequently completed his internship and residency at UT Southwestern Medical Center/Parkland Hospital System in Dallas, and completed his hematology/medical oncology fellowship at the University of Texas Health Science Center at San Antonio.
Also during his fellowship, Dr. Zoghi conducted very important research focused on microRNA as a new treatment for chemotherapy-resistant breast cancer. He was awarded a patent for this novel therapy in breast cancer, which led to him receiving the Texas Society of Clinical Oncology Award.
His interests include the most recent developments in cancer therapy including immunotherapy, targeted therapy, and CAR-T cell therapy. His holistic approach in cancer therapy was the subject of a cover page article in MD News magazine.
In conjunction with his clinical duties, continual medical education has also been an important passion of Dr. Zoghi. As a Chairman of Graduate Medical Education at Methodist Healthcare System, he has been involved in the quality of education and work environment for fellows and residents in all programs. Dr. Zoghi is also an assistant professor of Medicine at the University of Texas Health Science Center at San Antonio.
Dr. Zoghi has won numerous awards such as Texas Super Doctor (2019, 2020, 2021), Early Career Physician Leader of the Year Award by American College of Physician, Texas Chapter (2019); Arrival Award: Beacon of Light (2019), and one of Top 20 Impact Makers Honorees (2020) just to name a few. He has received the distinguished honor of being named Fellow of American College of Physicians